Back to Journals » Therapeutics and Clinical Risk Management » Volume 1 » Issue 1

Editorial || FREE PAPER ||

Authors Garry Walsh

Published 15 April 2005 Volume 2005:1(1) Pages 1—1

Garry Walsh

Asthmatic and Allergic Inflammation Group, School of Medicine, University of Aberdeen, UK

Welcome to the first issue of Therapeutics and Clinical Risk Management – a new international peer-reviewed journal. As the title suggests, the journal will publish original research and review articles on the evidence and opinion behind new and existing therapies. A further aim will be to define the usage of these therapies in terms of ultimate uptake and acceptance by the patient and healthcare professional. This is an area that to date has been somewhat neglected, and Dove Medical Press are to be congratulated for the launch of a new title that addresses these vital issues in an era when evidence-based medicine is becoming ever more important. The remit of the journal will of necessity be a broad one and, in this respect, represents a considerable challenge to all involved.

Download Article [PDF] 

Readers of this article also read:

Cigarette smoking and colorectal cancer mortality among 602,242 Norwegian males and females

Parajuli R, Bjerkaas E, Tverdal A, Le Marchand L, Weiderpass E, Gram IT

Clinical Epidemiology 2014, 6:137-145

Published Date: 7 April 2014


Sørensen HT, Friborg S, Rungby J, Christiansen JS, Vaag A, Beck-Nielsen H

Clinical Epidemiology 2012, 4:49-50

Published Date: 20 December 2012

Review of photodynamic therapy in actinic keratosis and basal cell carcinoma

Marica B Ericson, Ann-Marie Wennberg, Olle Larkö

Therapeutics and Clinical Risk Management 2008, 4:1-9

Published Date: 8 February 2008

Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4

Shufeng Zhou, Eli Chan, Xiaotian Li, Min Huang

Therapeutics and Clinical Risk Management 2005, 1:3-13

Published Date: 15 April 2005

Elective open abdominal aortic aneurysm repair: a seven-year experience

Stuart MacKenzie, judith R Swan, Cate D’Este,  Allan D Spigelman

Therapeutics and Clinical Risk Management 2005, 1:27-31

Published Date: 15 April 2005